Middle East Molecular Diagnostics Market Opportunities, Share Value, Key Insights and Size Estimation by 2031

0
21

The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031. The growth in the Middle East molecular diagnostics market is expected to be driven by factors such as the increasing prevalence of infectious diseases and various types of cancer in the Middle East, rising awareness of personalized medicine and its acceptance, coupled with the significant number of funding for executing RD in Middle East region.

Recent Developments in Middle East Molecular Diagnostics Market

• In January 2022, Abbott showcased its life-changing diagnostic tools and medical devices product portfolio for point-of-care testing (POCT) that helped COVID-19, diabetes, and cardiovascular disease patients at MEDLAB Middle East.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here